Global Long-acting and Short-acting Oral Contraceptives Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Long-acting and Short-acting Oral Contraceptives market size was valued at USD 628.7 million in 2023 and is forecast to a readjusted size of USD 781.6 million by 2030 with a CAGR of 3.2% during review period.

Oral contraceptives (birth control pills) are hormone-containing medications that are taken by mouth to prevent pregnancy. They prevent pregnancy by inhibiting ovulation and also by preventing sperm from penetrating through the cervix.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Long-acting and Short-acting Oral Contraceptives industry chain, the market status of Hospital Pharmacies (Combined Contraceptive Pill, Low Dose Oral Contraceptive), Private Clinics (Combined Contraceptive Pill, Low Dose Oral Contraceptive), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Long-acting and Short-acting Oral Contraceptives.

Regionally, the report analyzes the Long-acting and Short-acting Oral Contraceptives markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Long-acting and Short-acting Oral Contraceptives market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Long-acting and Short-acting Oral Contraceptives market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Long-acting and Short-acting Oral Contraceptives industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Combined Contraceptive Pill, Low Dose Oral Contraceptive).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Long-acting and Short-acting Oral Contraceptives market.

Regional Analysis: The report involves examining the Long-acting and Short-acting Oral Contraceptives market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Long-acting and Short-acting Oral Contraceptives market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Long-acting and Short-acting Oral Contraceptives:
Company Analysis: Report covers individual Long-acting and Short-acting Oral Contraceptives manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Long-acting and Short-acting Oral Contraceptives This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Private Clinics).

Technology Analysis: Report covers specific technologies relevant to Long-acting and Short-acting Oral Contraceptives. It assesses the current state, advancements, and potential future developments in Long-acting and Short-acting Oral Contraceptives areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Long-acting and Short-acting Oral Contraceptives market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Long-acting and Short-acting Oral Contraceptives market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Combined Contraceptive Pill
    Low Dose Oral Contraceptive

Market segment by Application
    Hospital Pharmacies
    Private Clinics
    Retail Pharmacies
    E-Commerce

Major players covered
    Bayer
    Paladin Labs
    Theramex (Teva)
    Pfizer
    Apotex
    HRA Pharma
    HLL Life Care
    Mankind
    Piramal
    Allergan

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Long-acting and Short-acting Oral Contraceptives product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Long-acting and Short-acting Oral Contraceptives, with price, sales, revenue and global market share of Long-acting and Short-acting Oral Contraceptives from 2019 to 2024.
Chapter 3, the Long-acting and Short-acting Oral Contraceptives competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Long-acting and Short-acting Oral Contraceptives breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Long-acting and Short-acting Oral Contraceptives market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Long-acting and Short-acting Oral Contraceptives.
Chapter 14 and 15, to describe Long-acting and Short-acting Oral Contraceptives sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Long-acting and Short-acting Oral Contraceptives
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Combined Contraceptive Pill
        1.3.3 Low Dose Oral Contraceptive
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital Pharmacies
        1.4.3 Private Clinics
        1.4.4 Retail Pharmacies
        1.4.5 E-Commerce
    1.5 Global Long-acting and Short-acting Oral Contraceptives Market Size & Forecast
        1.5.1 Global Long-acting and Short-acting Oral Contraceptives Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Long-acting and Short-acting Oral Contraceptives Sales Quantity (2019-2030)
        1.5.3 Global Long-acting and Short-acting Oral Contraceptives Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Bayer
        2.1.1 Bayer Details
        2.1.2 Bayer Major Business
        2.1.3 Bayer Long-acting and Short-acting Oral Contraceptives Product and Services
        2.1.4 Bayer Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Bayer Recent Developments/Updates
    2.2 Paladin Labs
        2.2.1 Paladin Labs Details
        2.2.2 Paladin Labs Major Business
        2.2.3 Paladin Labs Long-acting and Short-acting Oral Contraceptives Product and Services
        2.2.4 Paladin Labs Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Paladin Labs Recent Developments/Updates
    2.3 Theramex (Teva)
        2.3.1 Theramex (Teva) Details
        2.3.2 Theramex (Teva) Major Business
        2.3.3 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product and Services
        2.3.4 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Theramex (Teva) Recent Developments/Updates
    2.4 Pfizer
        2.4.1 Pfizer Details
        2.4.2 Pfizer Major Business
        2.4.3 Pfizer Long-acting and Short-acting Oral Contraceptives Product and Services
        2.4.4 Pfizer Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Pfizer Recent Developments/Updates
    2.5 Apotex
        2.5.1 Apotex Details
        2.5.2 Apotex Major Business
        2.5.3 Apotex Long-acting and Short-acting Oral Contraceptives Product and Services
        2.5.4 Apotex Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Apotex Recent Developments/Updates
    2.6 HRA Pharma
        2.6.1 HRA Pharma Details
        2.6.2 HRA Pharma Major Business
        2.6.3 HRA Pharma Long-acting and Short-acting Oral Contraceptives Product and Services
        2.6.4 HRA Pharma Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 HRA Pharma Recent Developments/Updates
    2.7 HLL Life Care
        2.7.1 HLL Life Care Details
        2.7.2 HLL Life Care Major Business
        2.7.3 HLL Life Care Long-acting and Short-acting Oral Contraceptives Product and Services
        2.7.4 HLL Life Care Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 HLL Life Care Recent Developments/Updates
    2.8 Mankind
        2.8.1 Mankind Details
        2.8.2 Mankind Major Business
        2.8.3 Mankind Long-acting and Short-acting Oral Contraceptives Product and Services
        2.8.4 Mankind Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Mankind Recent Developments/Updates
    2.9 Piramal
        2.9.1 Piramal Details
        2.9.2 Piramal Major Business
        2.9.3 Piramal Long-acting and Short-acting Oral Contraceptives Product and Services
        2.9.4 Piramal Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Piramal Recent Developments/Updates
    2.10 Allergan
        2.10.1 Allergan Details
        2.10.2 Allergan Major Business
        2.10.3 Allergan Long-acting and Short-acting Oral Contraceptives Product and Services
        2.10.4 Allergan Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Allergan Recent Developments/Updates

3 Competitive Environment: Long-acting and Short-acting Oral Contraceptives by Manufacturer
    3.1 Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Long-acting and Short-acting Oral Contraceptives Revenue by Manufacturer (2019-2024)
    3.3 Global Long-acting and Short-acting Oral Contraceptives Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Long-acting and Short-acting Oral Contraceptives by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Long-acting and Short-acting Oral Contraceptives Manufacturer Market Share in 2023
        3.4.2 Top 6 Long-acting and Short-acting Oral Contraceptives Manufacturer Market Share in 2023
    3.5 Long-acting and Short-acting Oral Contraceptives Market: Overall Company Footprint Analysis
        3.5.1 Long-acting and Short-acting Oral Contraceptives Market: Region Footprint
        3.5.2 Long-acting and Short-acting Oral Contraceptives Market: Company Product Type Footprint
        3.5.3 Long-acting and Short-acting Oral Contraceptives Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Long-acting and Short-acting Oral Contraceptives Market Size by Region
        4.1.1 Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Region (2019-2030)
        4.1.2 Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Region (2019-2030)
        4.1.3 Global Long-acting and Short-acting Oral Contraceptives Average Price by Region (2019-2030)
    4.2 North America Long-acting and Short-acting Oral Contraceptives Consumption Value (2019-2030)
    4.3 Europe Long-acting and Short-acting Oral Contraceptives Consumption Value (2019-2030)
    4.4 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Consumption Value (2019-2030)
    4.5 South America Long-acting and Short-acting Oral Contraceptives Consumption Value (2019-2030)
    4.6 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2019-2030)
    5.2 Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Type (2019-2030)
    5.3 Global Long-acting and Short-acting Oral Contraceptives Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2019-2030)
    6.2 Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Application (2019-2030)
    6.3 Global Long-acting and Short-acting Oral Contraceptives Average Price by Application (2019-2030)

7 North America
    7.1 North America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2019-2030)
    7.2 North America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2019-2030)
    7.3 North America Long-acting and Short-acting Oral Contraceptives Market Size by Country
        7.3.1 North America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Country (2019-2030)
        7.3.2 North America Long-acting and Short-acting Oral Contraceptives Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2019-2030)
    8.2 Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2019-2030)
    8.3 Europe Long-acting and Short-acting Oral Contraceptives Market Size by Country
        8.3.1 Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity by Country (2019-2030)
        8.3.2 Europe Long-acting and Short-acting Oral Contraceptives Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Market Size by Region
        9.3.1 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2019-2030)
    10.2 South America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2019-2030)
    10.3 South America Long-acting and Short-acting Oral Contraceptives Market Size by Country
        10.3.1 South America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Country (2019-2030)
        10.3.2 South America Long-acting and Short-acting Oral Contraceptives Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Long-acting and Short-acting Oral Contraceptives Market Size by Country
        11.3.1 Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Long-acting and Short-acting Oral Contraceptives Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Long-acting and Short-acting Oral Contraceptives Market Drivers
    12.2 Long-acting and Short-acting Oral Contraceptives Market Restraints
    12.3 Long-acting and Short-acting Oral Contraceptives Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Long-acting and Short-acting Oral Contraceptives and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Long-acting and Short-acting Oral Contraceptives
    13.3 Long-acting and Short-acting Oral Contraceptives Production Process
    13.4 Long-acting and Short-acting Oral Contraceptives Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Long-acting and Short-acting Oral Contraceptives Typical Distributors
    14.3 Long-acting and Short-acting Oral Contraceptives Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Bayer Basic Information, Manufacturing Base and Competitors
    Table 4. Bayer Major Business
    Table 5. Bayer Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 6. Bayer Long-acting and Short-acting Oral Contraceptives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Bayer Recent Developments/Updates
    Table 8. Paladin Labs Basic Information, Manufacturing Base and Competitors
    Table 9. Paladin Labs Major Business
    Table 10. Paladin Labs Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 11. Paladin Labs Long-acting and Short-acting Oral Contraceptives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Paladin Labs Recent Developments/Updates
    Table 13. Theramex (Teva) Basic Information, Manufacturing Base and Competitors
    Table 14. Theramex (Teva) Major Business
    Table 15. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 16. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Theramex (Teva) Recent Developments/Updates
    Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 19. Pfizer Major Business
    Table 20. Pfizer Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 21. Pfizer Long-acting and Short-acting Oral Contraceptives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Pfizer Recent Developments/Updates
    Table 23. Apotex Basic Information, Manufacturing Base and Competitors
    Table 24. Apotex Major Business
    Table 25. Apotex Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 26. Apotex Long-acting and Short-acting Oral Contraceptives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Apotex Recent Developments/Updates
    Table 28. HRA Pharma Basic Information, Manufacturing Base and Competitors
    Table 29. HRA Pharma Major Business
    Table 30. HRA Pharma Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 31. HRA Pharma Long-acting and Short-acting Oral Contraceptives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. HRA Pharma Recent Developments/Updates
    Table 33. HLL Life Care Basic Information, Manufacturing Base and Competitors
    Table 34. HLL Life Care Major Business
    Table 35. HLL Life Care Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 36. HLL Life Care Long-acting and Short-acting Oral Contraceptives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. HLL Life Care Recent Developments/Updates
    Table 38. Mankind Basic Information, Manufacturing Base and Competitors
    Table 39. Mankind Major Business
    Table 40. Mankind Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 41. Mankind Long-acting and Short-acting Oral Contraceptives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Mankind Recent Developments/Updates
    Table 43. Piramal Basic Information, Manufacturing Base and Competitors
    Table 44. Piramal Major Business
    Table 45. Piramal Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 46. Piramal Long-acting and Short-acting Oral Contraceptives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Piramal Recent Developments/Updates
    Table 48. Allergan Basic Information, Manufacturing Base and Competitors
    Table 49. Allergan Major Business
    Table 50. Allergan Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 51. Allergan Long-acting and Short-acting Oral Contraceptives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. Allergan Recent Developments/Updates
    Table 53. Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 54. Global Long-acting and Short-acting Oral Contraceptives Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 55. Global Long-acting and Short-acting Oral Contraceptives Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 56. Market Position of Manufacturers in Long-acting and Short-acting Oral Contraceptives, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 57. Head Office and Long-acting and Short-acting Oral Contraceptives Production Site of Key Manufacturer
    Table 58. Long-acting and Short-acting Oral Contraceptives Market: Company Product Type Footprint
    Table 59. Long-acting and Short-acting Oral Contraceptives Market: Company Product Application Footprint
    Table 60. Long-acting and Short-acting Oral Contraceptives New Market Entrants and Barriers to Market Entry
    Table 61. Long-acting and Short-acting Oral Contraceptives Mergers, Acquisition, Agreements, and Collaborations
    Table 62. Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Region (2019-2024) & (K Units)
    Table 63. Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Region (2025-2030) & (K Units)
    Table 64. Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Region (2019-2024) & (USD Million)
    Table 65. Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Region (2025-2030) & (USD Million)
    Table 66. Global Long-acting and Short-acting Oral Contraceptives Average Price by Region (2019-2024) & (US$/Unit)
    Table 67. Global Long-acting and Short-acting Oral Contraceptives Average Price by Region (2025-2030) & (US$/Unit)
    Table 68. Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2019-2024) & (K Units)
    Table 69. Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2025-2030) & (K Units)
    Table 70. Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Type (2019-2024) & (USD Million)
    Table 71. Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Type (2025-2030) & (USD Million)
    Table 72. Global Long-acting and Short-acting Oral Contraceptives Average Price by Type (2019-2024) & (US$/Unit)
    Table 73. Global Long-acting and Short-acting Oral Contraceptives Average Price by Type (2025-2030) & (US$/Unit)
    Table 74. Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2019-2024) & (K Units)
    Table 75. Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2025-2030) & (K Units)
    Table 76. Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Application (2019-2024) & (USD Million)
    Table 77. Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Application (2025-2030) & (USD Million)
    Table 78. Global Long-acting and Short-acting Oral Contraceptives Average Price by Application (2019-2024) & (US$/Unit)
    Table 79. Global Long-acting and Short-acting Oral Contraceptives Average Price by Application (2025-2030) & (US$/Unit)
    Table 80. North America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2019-2024) & (K Units)
    Table 81. North America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2025-2030) & (K Units)
    Table 82. North America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2019-2024) & (K Units)
    Table 83. North America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2025-2030) & (K Units)
    Table 84. North America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Country (2019-2024) & (K Units)
    Table 85. North America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Country (2025-2030) & (K Units)
    Table 86. North America Long-acting and Short-acting Oral Contraceptives Consumption Value by Country (2019-2024) & (USD Million)
    Table 87. North America Long-acting and Short-acting Oral Contraceptives Consumption Value by Country (2025-2030) & (USD Million)
    Table 88. Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2019-2024) & (K Units)
    Table 89. Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2025-2030) & (K Units)
    Table 90. Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2019-2024) & (K Units)
    Table 91. Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2025-2030) & (K Units)
    Table 92. Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity by Country (2019-2024) & (K Units)
    Table 93. Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity by Country (2025-2030) & (K Units)
    Table 94. Europe Long-acting and Short-acting Oral Contraceptives Consumption Value by Country (2019-2024) & (USD Million)
    Table 95. Europe Long-acting and Short-acting Oral Contraceptives Consumption Value by Country (2025-2030) & (USD Million)
    Table 96. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2019-2024) & (K Units)
    Table 97. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2025-2030) & (K Units)
    Table 98. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2019-2024) & (K Units)
    Table 99. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2025-2030) & (K Units)
    Table 100. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity by Region (2019-2024) & (K Units)
    Table 101. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity by Region (2025-2030) & (K Units)
    Table 102. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Consumption Value by Region (2019-2024) & (USD Million)
    Table 103. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Consumption Value by Region (2025-2030) & (USD Million)
    Table 104. South America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2019-2024) & (K Units)
    Table 105. South America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2025-2030) & (K Units)
    Table 106. South America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2019-2024) & (K Units)
    Table 107. South America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2025-2030) & (K Units)
    Table 108. South America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Country (2019-2024) & (K Units)
    Table 109. South America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Country (2025-2030) & (K Units)
    Table 110. South America Long-acting and Short-acting Oral Contraceptives Consumption Value by Country (2019-2024) & (USD Million)
    Table 111. South America Long-acting and Short-acting Oral Contraceptives Consumption Value by Country (2025-2030) & (USD Million)
    Table 112. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2019-2024) & (K Units)
    Table 113. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2025-2030) & (K Units)
    Table 114. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2019-2024) & (K Units)
    Table 115. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2025-2030) & (K Units)
    Table 116. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity by Region (2019-2024) & (K Units)
    Table 117. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity by Region (2025-2030) & (K Units)
    Table 118. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Consumption Value by Region (2019-2024) & (USD Million)
    Table 119. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Consumption Value by Region (2025-2030) & (USD Million)
    Table 120. Long-acting and Short-acting Oral Contraceptives Raw Material
    Table 121. Key Manufacturers of Long-acting and Short-acting Oral Contraceptives Raw Materials
    Table 122. Long-acting and Short-acting Oral Contraceptives Typical Distributors
    Table 123. Long-acting and Short-acting Oral Contraceptives Typical Customers
List of Figures
    Figure 1. Long-acting and Short-acting Oral Contraceptives Picture
    Figure 2. Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Long-acting and Short-acting Oral Contraceptives Consumption Value Market Share by Type in 2023
    Figure 4. Combined Contraceptive Pill Examples
    Figure 5. Low Dose Oral Contraceptive Examples
    Figure 6. Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Long-acting and Short-acting Oral Contraceptives Consumption Value Market Share by Application in 2023
    Figure 8. Hospital Pharmacies Examples
    Figure 9. Private Clinics Examples
    Figure 10. Retail Pharmacies Examples
    Figure 11. E-Commerce Examples
    Figure 12. Global Long-acting and Short-acting Oral Contraceptives Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global Long-acting and Short-acting Oral Contraceptives Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Long-acting and Short-acting Oral Contraceptives Sales Quantity (2019-2030) & (K Units)
    Figure 15. Global Long-acting and Short-acting Oral Contraceptives Average Price (2019-2030) & (US$/Unit)
    Figure 16. Global Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Manufacturer in 2023
    Figure 17. Global Long-acting and Short-acting Oral Contraceptives Consumption Value Market Share by Manufacturer in 2023
    Figure 18. Producer Shipments of Long-acting and Short-acting Oral Contraceptives by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 19. Top 3 Long-acting and Short-acting Oral Contraceptives Manufacturer (Consumption Value) Market Share in 2023
    Figure 20. Top 6 Long-acting and Short-acting Oral Contraceptives Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Global Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Region (2019-2030)
    Figure 22. Global Long-acting and Short-acting Oral Contraceptives Consumption Value Market Share by Region (2019-2030)
    Figure 23. North America Long-acting and Short-acting Oral Contraceptives Consumption Value (2019-2030) & (USD Million)
    Figure 24. Europe Long-acting and Short-acting Oral Contraceptives Consumption Value (2019-2030) & (USD Million)
    Figure 25. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Consumption Value (2019-2030) & (USD Million)
    Figure 26. South America Long-acting and Short-acting Oral Contraceptives Consumption Value (2019-2030) & (USD Million)
    Figure 27. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Consumption Value (2019-2030) & (USD Million)
    Figure 28. Global Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Type (2019-2030)
    Figure 29. Global Long-acting and Short-acting Oral Contraceptives Consumption Value Market Share by Type (2019-2030)
    Figure 30. Global Long-acting and Short-acting Oral Contraceptives Average Price by Type (2019-2030) & (US$/Unit)
    Figure 31. Global Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Application (2019-2030)
    Figure 32. Global Long-acting and Short-acting Oral Contraceptives Consumption Value Market Share by Application (2019-2030)
    Figure 33. Global Long-acting and Short-acting Oral Contraceptives Average Price by Application (2019-2030) & (US$/Unit)
    Figure 34. North America Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Type (2019-2030)
    Figure 35. North America Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Application (2019-2030)
    Figure 36. North America Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Country (2019-2030)
    Figure 37. North America Long-acting and Short-acting Oral Contraceptives Consumption Value Market Share by Country (2019-2030)
    Figure 38. United States Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Canada Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Mexico Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Type (2019-2030)
    Figure 42. Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Application (2019-2030)
    Figure 43. Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Country (2019-2030)
    Figure 44. Europe Long-acting and Short-acting Oral Contraceptives Consumption Value Market Share by Country (2019-2030)
    Figure 45. Germany Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. France Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. United Kingdom Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Russia Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Italy Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Type (2019-2030)
    Figure 51. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Application (2019-2030)
    Figure 52. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Region (2019-2030)
    Figure 53. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Consumption Value Market Share by Region (2019-2030)
    Figure 54. China Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Japan Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Korea Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. India Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Southeast Asia Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Australia Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. South America Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Type (2019-2030)
    Figure 61. South America Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Application (2019-2030)
    Figure 62. South America Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Country (2019-2030)
    Figure 63. South America Long-acting and Short-acting Oral Contraceptives Consumption Value Market Share by Country (2019-2030)
    Figure 64. Brazil Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. Argentina Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Type (2019-2030)
    Figure 67. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Application (2019-2030)
    Figure 68. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity Market Share by Region (2019-2030)
    Figure 69. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Consumption Value Market Share by Region (2019-2030)
    Figure 70. Turkey Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Egypt Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Saudi Arabia Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. South Africa Long-acting and Short-acting Oral Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. Long-acting and Short-acting Oral Contraceptives Market Drivers
    Figure 75. Long-acting and Short-acting Oral Contraceptives Market Restraints
    Figure 76. Long-acting and Short-acting Oral Contraceptives Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Long-acting and Short-acting Oral Contraceptives in 2023
    Figure 79. Manufacturing Process Analysis of Long-acting and Short-acting Oral Contraceptives
    Figure 80. Long-acting and Short-acting Oral Contraceptives Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Companies Mentioned

Bayer
Paladin Labs
Theramex (Teva)
Pfizer
Apotex
HRA Pharma
HLL Life Care
Mankind
Piramal
Allergan